MRI Guided Ultrasound Devices Industry Growth Report

Comments · 8 Views

MRI-guided focused ultrasound (MRgFUS) surgery is an innovative, minimally invasive procedure that leverages magnetic resonance imaging (MRI) for accurate targeting, treatment planning, and real-time monitoring of energy delivery.

According to FutureWise analysis the MRI Guided and Focused Ultrasound Devices Market in 2025 is US$ 7.18 billion, and is expected to reach US$ 15.02 billion by 2033 at a CAGR of 9.67%. These devices are transforming non-invasive therapeutic procedures by allowing for the precise targeting of tumors, neurological disorders, and other conditions without the need for surgery. Improvements in imaging accuracy and real-time monitoring are broadening their clinical applications, leading to better patient outcomes and shorter recovery times.

MRI-guided focused ultrasound (MRgFUS) surgery is an innovative, minimally invasive procedure that leverages magnetic resonance imaging (MRI) for accurate targeting, treatment planning, and real-time monitoring of energy delivery. By combining focused ultrasound (FUS) with MRI, this technique allows for precise localization and ablation of targeted tissue while preserving surrounding healthy structures. As a result, MRgFUS serves as a promising alternative to traditional surgical methods and radiation therapy for both benign and malignant tumors.

Currently approved for the treatment of uterine fibroids, MRgFUS is also undergoing clinical trials for a range of other conditions, including Parkinson's disease, neuropathic pain, liver cancer, prostate cancer, breast cancer, brain cancer, and relief from pain associated with bone metastasis. Beyond thermal ablation, FUS can enhance the permeability of vascular or cellular membranes—either on its own or in conjunction with microbubbles—facilitating targeted drug delivery or gene activation for therapeutic purposes.

As a groundbreaking technology, MRgFUS holds the potential to transform patient care across various medical disciplines, offering new therapeutic options and reshaping existing treatment paradigms.

Enhanced Imaging Precision: Advancements in MRI technology have significantly enhanced the spatial resolution and real-time imaging capabilities of focused ultrasound systems. This improvement allows for more precise targeting of tissues, minimizing the risk of damage to surrounding healthy areas.

Integration with Artificial Intelligence: Integrating AI algorithms into MRI-guided focused ultrasound systems has improved automated treatment planning and monitoring, thus optimizing therapeutic outcomes and enhancing workflow efficiency in clinical settings.

FutureWise Market Research has published a report that provides an insightful analysis of MRI Guided and Focused Ultrasound Devices Market trends that are affecting the overall market growth.

Request a Free Sample @
 https://www.futurewiseresearch.com/contact.aspx?rpt=261&type=requestsample

MRI Guided and Focused Ultrasound Devices Market Segmentation:

By Product

  • Magnetic Resonance Guided
  • Ultrasound
  • Magnetic Resonance and Ultrasound Guided

By Indications

  • Uterine Fibroids
  • Prostate Diseases
  • Liver Cancer
  • Glaucoma
  • Bone metastases
  • Breast Cancer
  • Brain

By End User

  • Academic and Research Institutes
  • Hospitals

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Competitive Landscape in MRI Guided and Focused Ultrasound Devices Market:

  • Toshiba Corporation
  • Siemens AG
  • FUJIFILM Holdings Corporation
  • Hitachi Ltd
  • Analogic Corporationresonance-guided
  • Mindray Medical International Ltd.

Recent developments by key players in MRI Guided and Focused Ultrasound Devices Market:

Siemens 

Siemens announced a co-sales and marketing partnership with Profound Medical in December 2024. This agreement will combine Siemens' high-performance Magnetom Free.Max™ MRI system with Profound's TULSA-PRO® system, creating a comprehensive solution for MRI-guided prostate therapy. The collaboration aims to enable real-time precision ablation through an integrated hardware and software workflow

FUJIFILM 

In August 2023, FUJIFILM Healthcare Americas introduced the ECHELON Synergy 1.5T MRI system, which includes Synergy DLR deep-learning reconstruction technology for faster and clearer scans. These enhancements support MRgFUS workflows by improving image quality and minimizing motion artifacts during treatment targeting. 

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=261&license=multi

**Objectives of this Study: **

  1. To provide a comprehensive analysis of the MRI Guided and Focused Ultrasound Devices Market By Product Type, By Indication, By End-User and By Region.
  2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
  3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
  4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

                                                                                                                
Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
  • The customization services offered are free of charge with the purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
Comments

Everyone can earn money on Spark TV.
CLICK HERE